Literature DB >> 8741009

Involvement of leukotrienes in allergic pleurisy in actively sensitized rats: inhibition by the lipoxygenase inhibitor T-0757 of the increase in vascular permeability and leukotriene E4 production.

M Kikuchi1, K Tsuzurahara, T Suzuki, N Yato, K Naito.   

Abstract

The relative contributions of inflammatory mediators to the increase in vascular permeability in antigen-induced pleurisy were examined in rats actively sensitized with ovalbumin. The effects of various inhibitors were assessed on the exudate volume and plasma exudation rate in the pleural cavity. Two peaks were observed in plasma exudation rate at 0.5 and 3 h after antigen challenge. At 0.5 h, there was a marked decrease in the histamine content of the pleural cells and also a sharp increase in the LTE4 level in the exudate, which was inhibited dose-dependently by the lipoxygenase inhibitor T-0757. Indomethacin and cyproheptadine both depressed exudate volume and exudation rate, whereas T-0757 only reduced the exudation rate. At 3 h, a substantial LTE4 concentration was still detected in the exudate, and the exudation rate was depressed by T-0757 and indomethacin, but not by cyproheptadine. These results suggest that histamine is involved mainly in the early phase, and leukotrienes predominantly contribute to the later phase of exudation. Prostaglandins appear to be involved in both phases. Allergic pleurisy of rats, therefore, may be a suitable model to examine the roles of these inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741009     DOI: 10.1007/bf02285160

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  19 in total

1.  Pulmonary and vascular actions of leukotrienes.

Authors:  P Hedqvist; S E Dahlén; J Björk
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1982

2.  The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin.

Authors:  M J Peck; P J Piper; T J Williams
Journal:  Prostaglandins       Date:  1981-02

3.  A possible role of arachidonate metabolism in allergic air pouch inflammation in rats. Anti-inflammatory effect of indomethacin and dexamethasone and the level of prostaglandin E2 in the exudate.

Authors:  K Ohuchi; S Yoshino; K Kanaoka; S Tsurufuji; L Levine
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

4.  Effects of TZI-41127, a novel selective 5-lipoxygenase inhibitor, on A23187-induced pleurisy in rats.

Authors:  M Hagiwara; T Mikami; S Iwamura; K Miyazawa; M Kobayashi; K Miyasaka
Journal:  Eur J Pharmacol       Date:  1991-06-18       Impact factor: 4.432

Review 5.  Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents.

Authors:  J A Salmon; L G Garland
Journal:  Prog Drug Res       Date:  1991

6.  Accumulation of leukotriene C4 and histamine in human allergic skin reactions.

Authors:  S F Talbot; P C Atkins; E J Goetzl; B Zweiman
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  4-acylaminophenol derivatives as novel lipoxygenase inhibitors: synthesis and inhibitory effect on 5-lipoxygenase and leukotriene B4 production.

Authors:  M Kikuchi; Y Hashimura; K Tsuzurahara; M Nagasawa; H Inoue; T Taniguchi; T Uchida
Journal:  Biol Pharm Bull       Date:  1994-08       Impact factor: 2.233

8.  Involvement of leukotrienes in allergic inflammation in mice.

Authors:  C Zuany-Amorim; R S Cordeiro; B B Vargaftig
Journal:  Eur J Pharmacol       Date:  1994-05-23       Impact factor: 4.432

9.  Metabolism of leukotriene C4, D4 and E4 in allergic inflammation in rats.

Authors:  K Ohuchi; C Takahashi; M Watanabe; N Hirasawa; Y Suzuki; M Kudo; T Konishi; S Tsurufuji
Journal:  J Clin Lab Immunol       Date:  1988-12

10.  Inhibitory effect of 4-acylaminophenol derivatives (T-0799 and T-0757), novel lipoxygenase inhibitors, on arachidonic acid-induced infiltration of polymorphonuclear leukocytes in rat skin.

Authors:  M Kikuchi; S Ishikawa; K Tsuzurahara
Journal:  Jpn J Pharmacol       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.